Clinical trial

Denosumab for Type 1 Diabetes

NCT06524960

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-03

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2024-09-03Date precision: day

Registry last updated2026-07-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

DenosumabDRUG · verified · RxNorm: denosumab

PlaceboOTHER

Sponsors & collaborators

City of Hope Medical Centerlead sponsor

Mapped research locations

BirminghamAlabama, United States1 IndianapolisIndiana, United States1 DuarteCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06524960 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.